199 related articles for article (PubMed ID: 26408929)
1. Deleterious vascular effects of indoxyl sulfate and reversal by oral adsorbent AST-120.
Six I; Gross P; Rémond MC; Chillon JM; Poirot S; Drueke TB; Massy ZA
Atherosclerosis; 2015 Nov; 243(1):248-56. PubMed ID: 26408929
[TBL] [Abstract][Full Text] [Related]
2. Reduction of indoxyl sulfate by AST-120 attenuates monocyte inflammation related to chronic kidney disease.
Ito S; Higuchi Y; Yagi Y; Nishijima F; Yamato H; Ishii H; Osaka M; Yoshida M
J Leukoc Biol; 2013 Jun; 93(6):837-45. PubMed ID: 23362306
[TBL] [Abstract][Full Text] [Related]
3. The protein metabolite hypothesis, a model for the progression of renal failure: an oral adsorbent lowers indoxyl sulfate levels in undialyzed uremic patients.
Niwa T; Nomura T; Sugiyama S; Miyazaki T; Tsukushi S; Tsutsui S
Kidney Int Suppl; 1997 Nov; 62():S23-8. PubMed ID: 9350673
[TBL] [Abstract][Full Text] [Related]
4. Effects of phosphate on vascular function under normal conditions and influence of the uraemic state.
Six I; Maizel J; Barreto FC; Rangrez AY; Dupont S; Slama M; Tribouilloy C; Choukroun G; Mazière JC; Bode-Boeger S; Kielstein JT; Drüeke TB; Massy ZA
Cardiovasc Res; 2012 Oct; 96(1):130-9. PubMed ID: 22822101
[TBL] [Abstract][Full Text] [Related]
5. Role of indoxyl sulfate in the progression of chronic kidney disease and cardiovascular disease: experimental and clinical effects of oral sorbent AST-120.
Niwa T
Ther Apher Dial; 2011 Apr; 15(2):120-4. PubMed ID: 21426500
[TBL] [Abstract][Full Text] [Related]
6. Oral adsorbent AST-120 ameliorates endothelial dysfunction independent of renal function in rats with subtotal nephrectomy.
Namikoshi T; Tomita N; Satoh M; Sakuta T; Kuwabara A; Kobayashi S; Higuchi Y; Nishijima F; Kashihara N
Hypertens Res; 2009 Mar; 32(3):194-200. PubMed ID: 19262482
[TBL] [Abstract][Full Text] [Related]
7. Indoxyl sulfate is a nephro-vascular toxin.
Niwa T
J Ren Nutr; 2010 Sep; 20(5 Suppl):S2-6. PubMed ID: 20797565
[TBL] [Abstract][Full Text] [Related]
8. Uremic toxicity of indoxyl sulfate.
Niwa T
Nagoya J Med Sci; 2010 Feb; 72(1-2):1-11. PubMed ID: 20229698
[TBL] [Abstract][Full Text] [Related]
9. [Effect of oral sorbent, AST-120, on serum concentration of indoxyl sulfate in uremic rats].
Niwa T; Yazawa T; Maeda K; Ise M; Sugano M; Kodama T; Uehara Y
Nihon Jinzo Gakkai Shi; 1990 Jun; 32(6):695-701. PubMed ID: 2120492
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of VCAM-1 and ICAM-1 at atherosclerosis-prone sites on the endothelium in the ApoE-deficient mouse.
Nakashima Y; Raines EW; Plump AS; Breslow JL; Ross R
Arterioscler Thromb Vasc Biol; 1998 May; 18(5):842-51. PubMed ID: 9598845
[TBL] [Abstract][Full Text] [Related]
11. Role of oxidative stress and indoxyl sulfate in progression of cardiovascular disease in chronic kidney disease.
Fujii H; Nakai K; Fukagawa M
Ther Apher Dial; 2011 Apr; 15(2):125-8. PubMed ID: 21426501
[TBL] [Abstract][Full Text] [Related]
12. Effects of AST-120 on blood concentrations of protein-bound uremic toxins and biomarkers of cardiovascular risk in chronic dialysis patients.
Lee CT; Hsu CY; Tain YL; Ng HY; Cheng BC; Yang CC; Wu CH; Chiou TT; Lee YT; Liao SC
Blood Purif; 2014; 37(1):76-83. PubMed ID: 24576840
[TBL] [Abstract][Full Text] [Related]
13. AST-120 ameliorates lowered exercise capacity and mitochondrial biogenesis in the skeletal muscle from mice with chronic kidney disease via reducing oxidative stress.
Nishikawa M; Ishimori N; Takada S; Saito A; Kadoguchi T; Furihata T; Fukushima A; Matsushima S; Yokota T; Kinugawa S; Tsutsui H
Nephrol Dial Transplant; 2015 Jun; 30(6):934-42. PubMed ID: 25878055
[TBL] [Abstract][Full Text] [Related]
14. Oral activated charcoal adsorbent (AST-120) ameliorates extent and instability of atherosclerosis accelerated by kidney disease in apolipoprotein E-deficient mice.
Yamamoto S; Zuo Y; Ma J; Yancey PG; Hunley TE; Motojima M; Fogo AB; Linton MF; Fazio S; Ichikawa I; Kon V
Nephrol Dial Transplant; 2011 Aug; 26(8):2491-7. PubMed ID: 21245127
[TBL] [Abstract][Full Text] [Related]
15. Lack of modulatory effect of simvastatin on indoxyl sulfate-induced activation of cultured endothelial cells.
Lee CT; Lee YT; Ng HY; Chiou TT; Cheng CI; Kuo CC; Wu CH; Chi PJ; Lee WC
Life Sci; 2012 Jan; 90(1-2):47-53. PubMed ID: 22056374
[TBL] [Abstract][Full Text] [Related]
16. Effects of the oral adsorbent AST-120 on tryptophan metabolism in uremic patients.
Tsubakihara Y; Takabatake Y; Oka K; Shoji T; Togawa M; Okada N; Takahito I; Imai E
Am J Kidney Dis; 2003 Mar; 41(3 Suppl 1):S38-41. PubMed ID: 12612950
[TBL] [Abstract][Full Text] [Related]
17. Oral charcoal adsorbent (AST-120) prevents progression of cardiac damage in chronic kidney disease through suppression of oxidative stress.
Fujii H; Nishijima F; Goto S; Sugano M; Yamato H; Kitazawa R; Kitazawa S; Fukagawa M
Nephrol Dial Transplant; 2009 Jul; 24(7):2089-95. PubMed ID: 19188341
[TBL] [Abstract][Full Text] [Related]
18. Metabolomic search for uremic toxins as indicators of the effect of an oral sorbent AST-120 by liquid chromatography/tandem mass spectrometry.
Kikuchi K; Itoh Y; Tateoka R; Ezawa A; Murakami K; Niwa T
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Nov; 878(29):2997-3002. PubMed ID: 20870466
[TBL] [Abstract][Full Text] [Related]
19. Indoxyl sulfate-lowering capacity of oral sorbents affects the prognosis of kidney function and oxidative stress in chronic kidney disease.
Taki K; Niwa T
J Ren Nutr; 2007 Jan; 17(1):48-52. PubMed ID: 17198932
[TBL] [Abstract][Full Text] [Related]
20. Administration of oral charcoal adsorbent (AST-120) suppresses low-turnover bone progression in uraemic rats.
Iwasaki Y; Yamato H; Nii-Kono T; Fujieda A; Uchida M; Hosokawa A; Motojima M; Fukagawa M
Nephrol Dial Transplant; 2006 Oct; 21(10):2768-74. PubMed ID: 16820376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
